Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B. | |
| https://doi.org/10.1172/jci20032 | Gene expression profiling predicts clinical outcome of prostate cancer |
| https://doi.org/10.1200/jco.2007.13.3934 | Individual Fluorouracil Dose Adjustment Based on Pharmacokinetic Follow-Up Compared With Conventional Dosage: Results of a Multicenter Randomized Trial of Patients With Metastatic Colorectal Cancer |
| https://doi.org/10.1038/nrclinonc.2015.169 | Drug repurposing in oncology—patient and health systems opportunities |
| https://doi.org/10.3332/ecancer.2017.781 | Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents |
| https://doi.org/10.3332/ecancer.2014.485 | Repurposing drugs in oncology (ReDO)—Cimetidine as an anti-cancer agent |
| https://doi.org/10.1016/s1470-2045(00)00292-8 | Marine organisms as a source of new anticancer agents |
| https://doi.org/10.1186/s13023-019-1075-8 | Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium |
| https://doi.org/10.1186/s40425-018-0381-3 | White paper on microbial anti-cancer therapy and prevention |
| https://doi.org/10.3332/ecancer.2015.521 | Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent |
| https://doi.org/10.3332/ecancer.2018.886 | ReDO_DB: the repurposing drugs in oncology database |
| https://doi.org/10.3332/ecancer.2016.610 | Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent |
| https://doi.org/10.4161/cc.8.6.7891 | Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain ofSalmonella typhymurium |
| https://doi.org/10.3332/ecancer.2016.680 | Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent |
| https://doi.org/10.4161/cc.9.22.13744 | Vessel destruction by tumor-targetingSalmonella typhimuriumA1-R is enhanced by high tumor vascularity |
| https://doi.org/10.4161/cc.10.5.14969 | The bulge area is the major hair follicle source of nestin-expressing pluripotent stem cells which can repair the spinal cord compared to the dermal papilla |
| https://doi.org/10.1007/s00216-015-8484-x | Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers |
| https://doi.org/10.1038/s41598-017-18924-4 | Vitamin E inhibits the UVAI induction of “light” and “dark” cyclobutane pyrimidine dimers, and oxidatively generated DNA damage, in keratinocytes |
| https://doi.org/10.3332/ecancer.2015.513 | Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent |
| https://doi.org/10.1016/j.trecan.2017.06.007 | Repurposing Drugs in Oncology: Next Steps |
| https://doi.org/10.3389/fphar.2019.01664 | On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients |
| https://doi.org/10.3389/fphar.2018.00637 | “Hard” Drug Repurposing for Precision Oncology: The Missing Link? |
| https://doi.org/10.1093/noajnl/vdab075 | A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3 |
| https://doi.org/10.1016/j.semcancer.2020.01.008 | Repurposing drugs in oncology: From candidate selection to clinical adoption |
| https://doi.org/10.1186/s12885-019-5676-3 | PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer |
| https://doi.org/10.3389/fphar.2021.627574 | An Open Access Database of Licensed Cancer Drugs |
| https://doi.org/10.3389/fnut.2018.00138 | A Phase 2 Study to Assess the Immunomodulatory Capacity of a Lecithin-based Delivery System of Curcumin in Endometrial Cancer |
| https://doi.org/10.1186/s13063-021-05273-x | Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research |
| https://doi.org/10.1007/s00262-022-03253-x | Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study |
| https://doi.org/10.3390/cancers16050998 | Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) |
| https://doi.org/10.3389/fonc.2021.688755 | Repurposing Infectious Diseases Vaccines Against Cancer |
| https://doi.org/10.1016/j.jcms.2024.12.009 | Evaluation of a context-aware chatbot using retrieval-augmented generation for answering clinical questions on medication-related osteonecrosis of the jaw |
| https://doi.org/10.1038/s41563-025-02188-9 | Biorhythm-mimicking growth hormone patch |
| https://doi.org/10.1002/path.6017 | |
| https://doi.org/10.1080/0284186x.2021.1953136 | Use of non-cancer drugs and survival among patients with pancreatic adenocarcinoma: a nationwide registry-based study in Norway |
| https://doi.org/10.3389/fonc.2019.01408 | Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue—Going Beyond Apoptosis Induction |
| https://doi.org/10.1038/s41467-024-53398-9 | Succinate dehydrogenase deficiency-driven succinate accumulation induces drug resistance in acute myeloid leukemia via ubiquitin-cullin regulation |
| https://doi.org/10.1186/s12943-025-02365-z | Targeting metastasis in paediatric bone sarcomas |
| https://doi.org/10.1016/s1470-2045(24)00736-8 | New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis |
| https://doi.org/10.1016/j.ygyno.2024.10.020 | Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial |
| https://doi.org/10.1021/acs.jmedchem.5c01025 | Antibacterial Metallacarborane-Peptide Hybrids Target the Membrane Potential in a Nonlytic Mode and Are Resistant to Proteolysis |
| https://doi.org/10.1016/j.eclinm.2025.103203 | Genetic predisposition in sarcomas: clinical implications and management |
| https://doi.org/10.1021/acs.jmedchem.5c01594 | Design, Synthesis and Biological Evaluation of 7-(1-Methyl-1H-indole-3-yl)-5H-pyrrolo[2,3-b]pyrazine Derivatives as Novel Covalent pan-FGFR Inhibitors to Overcome Clinical Resistance |
| https://doi.org/10.1158/0008-5472.can-06-0217 | Targeting the Lymphotoxin-β Receptor with Agonist Antibodies as a Potential Cancer Therapy |
| Methioninase cancer gene therapy with selenomethionine as suicide prodrug substrate. | |
| https://doi.org/10.1097/00000421-200210000-00015 | Phase II Trial of Cisplatin Plus Decitabine, a New DNA Hypomethylating Agent, in Patients With Advanced Squamous Cell Carcinoma of the Cervix |
| https://doi.org/10.1158/1078-0432.ccr-03-0068 | Pharmacokinetics, Methionine Depletion, and Antigenicity of Recombinant Methioninase in Primates |
| https://doi.org/10.1111/j.1939-1676.2010.0559.x | Ultrasonography Criteria for Differentiating ACTH Dependency from ACTH Independency in 47 Dogs with Hyperadrenocorticism and Equivocal Adrenal Asymmetry |
| https://doi.org/10.1007/s00253-005-0038-2 | High-level expression and bulk crystallization of recombinant l-methionine γ-lyase, an anticancer agent |
| https://doi.org/10.1016/j.otsr.2018.01.010 | Accuracy of patient-specific guided implantation of the glenoid component in reversed shoulder arthroplasty |
| https://doi.org/10.1111/j.1346-8138.2011.01413.x | Nestin‐positive hair follicle pluripotent stem cells can promote regeneration of impinged peripheral nerve injury |
| https://doi.org/10.1039/c6qo00526h | [3 + 2] Cycloaddition of aza-oxyallyl cations with aldehydes |
| https://doi.org/10.3332/ecancer.2015.568 | Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent |
| https://doi.org/10.1111/cen.13369 | Circulating thyroid cancer biomarkers: Current limitations and future prospects |
| https://doi.org/10.3332/ecancer.2018.824 | Repurposing drugs in oncology (ReDO)—selective PDE5 inhibitors as |
| https://doi.org/10.2217/fon.14.244 | Repurposing drugs in your medicine cabinet: untapped opportunities for cancer therapy? |
| https://doi.org/10.1093/carcin/bgs097 | Intervention of human breast cell carcinogenesis chronically induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine |
| https://doi.org/10.2147/ott.s42245 | Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer |
| https://doi.org/10.1016/j.ejca.2020.04.038 | Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents |
| https://doi.org/10.1111/j.1346-8138.2008.00578.x | Multipotent nestin‐expressing hair follicle stem cells |
| https://doi.org/10.1136/bmj.k2701 | New uses for old drugs |
| https://doi.org/10.1038/s43018-020-0030-x | Challenges and opportunities for cancer clinical trials in low- and middle-income countries |
| https://doi.org/10.1038/nrclinonc.2017.69 | Scientific advice — is drug repurposing missing a trick? |
| https://doi.org/10.2217/fon-2019-0233 | Journal Retractions in Oncology: A Bibliometric Study |
| https://doi.org/10.1016/j.ejca.2021.10.016 | Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer |
| https://doi.org/10.4161/cc.10.12.15895 | Watching stem cells in the skin of living mice noninvasively |
| https://doi.org/10.3332/ecancer.2015.ed50 | The wisdom of crowds and the repurposing of artesunate as an anticancer drug |
| https://doi.org/10.1016/s1470-2045(18)30076-7 | Cancer groundshot: going global before going to the moon |
| https://doi.org/10.1517/14712590902845610 | RANKL inhibition: Clinical implications for the management of patients with multiple myeloma and solid tumors with bone metastases |
| https://doi.org/10.1007/s00018-010-0265-2 | The corticotropin releasing factor system in cancer: expression and pathophysiological implications |
| https://doi.org/10.1111/j.1939-1676.2011.0773.x | Use of Computed Tomography Adrenal Gland Measurement for Differentiating ACTH Dependence from ACTH Independence in 64 Dogs with Hyperadenocorticism |
| https://doi.org/10.4149/neo_2019_190110n34 | Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review |
| https://doi.org/10.1159/000085617 | The Irinotecan/5-Fluorouracil Combination Induces Apoptosis and Enhances Manganese Superoxide Dismutase Activity in HT-29 Human Colon Carcinoma Cells |
| https://doi.org/10.1159/000076387 | Pituitary Metastasis of Follicular Thyroid Carcinoma |
| https://doi.org/10.3332/ecancer.2018.ed82 | Propranolol and breast cancer—a work in progress |
| https://doi.org/10.1080/2162402x.2015.1049802 | Cryoablation and Meriva have strong therapeutic effect on triple-negative breast cancer |
| https://doi.org/10.1136/jitc-2020-001250 | Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice |
| https://doi.org/10.3389/fphar.2021.790952 | A Database of Drug Repurposing Clinical Trials in Oncology |
| https://doi.org/10.4161/15384101.2014.991604 | Cell-cycle fate-monitoring distinguishes individual chemosensitive and chemoresistant cancer cells in drug-treated heterogeneous populations demonstrated by real-time FUCCI imaging |
| https://doi.org/10.1016/j.ejca.2020.08.014 | Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children |
| https://doi.org/10.1200/go.20.00591 | Trends in International Cancer Research Investment 2006-2018 |
| https://doi.org/10.1046/j.1365-2141.1999.01196.x | Course of the International Normalized Ratio in response to oral vitamin K1 in patients overanticoagulated with phenprocoumon |
| https://doi.org/10.1371/journal.pone.0225748 | Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-controlled clinical trial |
| https://doi.org/10.1111/php.13551 | Perspectives on Cyclobutane Pyrimidine Dimers—Rise of the Dark Dimers† |
| https://doi.org/10.1016/j.jcpo.2022.100375 | Cancer literacy – Informing patients and implementing shared decision making |
| https://doi.org/10.1016/j.ejca.2022.06.008 | Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas |
| https://doi.org/10.3389/fmed.2021.817663 | Repurposing of Medicines in the EU: Launch of a Pilot Framework |
| https://doi.org/10.1016/j.ejca.2017.07.021 | Orphan Drug Regulation: A missed opportunity for children and adolescents with cancer |
| https://doi.org/10.3389/fphar.2022.960701 | How to balance valuable innovation with affordable access to medicines in Belgium? |
| https://doi.org/10.3332/ecancer.2016.689 | Next generation metronomic chemotherapy—report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6–8 May 2016, Mumbai |
| https://doi.org/10.1200/go.22.00233 | European Cancer Organisation's Inequalities Network: Putting Cancer Inequalities on the European Policy Map |
| https://doi.org/10.1186/s13613-021-00925-2 | High mean arterial pressure target to improve sepsis-associated acute kidney injury in patients with prior hypertension: a feasibility study |
| https://doi.org/10.1200/jco.21.01916 | When Innovation and Commercialization Collide: A Patient Advocate View in Neuroblastoma |
| https://doi.org/10.1016/j.ejca.2023.112950 | Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration |
| https://doi.org/10.3389/fphar.2021.599598 | A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung) |
| https://doi.org/10.21873/cdp.10008 | Stereotactic Body Radiation Therapy Boost in Patients With Cervical Cancer Ineligible for Brachytherapy |
| https://doi.org/10.1158/1078-0432.ccr-24-0101 | Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement |
| https://doi.org/10.3389/fphar.2019.00287 | A Computational Model of Tumor Growth and Anakoinosis |
| https://doi.org/10.1016/j.annonc.2023.05.006 | Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy |
| https://doi.org/10.1016/j.ejmech.2022.114904 | 2-Phenoxy-3, 4′-bipyridine derivatives inhibit AURKB-dependent mitotic processes by disrupting its localization |